Corrigendum: Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes

Alexander Egeberg, Joseph F Merola, Knut Schäkel, Luis Puig, Patrick D Mahar, Isabella Yali Wang, Imre Pavo, Christopher Schuster, Christopher E M Griffiths

Fingeraftryk

Dyk ned i forskningsemnerne om 'Corrigendum: Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes'. Sammen danner de et unikt fingeraftryk.

Medicin og biovidenskab